Trial intelligence / Profile preview

Single-dose versus multiple-dose methotrexate for tubal pregnancy and subsequent fertility

IRCT201112178435N1Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Apr 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of methotrexate in Ectopic pregnancy (EP) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Treatment success rate, Adverse effects of methotrexate and 1 more. Started Apr 2010; status: completed.

02

Drugs

methotrexate
03

Conditions

Ectopic pregnancy (EP)

Beyond the preview

Go deeper on IRCT201112178435N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201112178435N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call